ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,206.12
0.36%
US Tech 100
17,641.40
0.22%
Dow Jones
39,304.34
0.63%
Brent Oil
83.425
-0.16%
Bitcoin
62,099.03
1.49%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aquestive Therapeutics Inc (AQST) Quote

Aquestive Therapeutics Inc

Aquestive Therapeutics Inc (AQST)

NASDAQ
3.29
0.205
( 6.65% )
Updated: 13:40:15
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.29
Bid
3.29
Ask
3.30
Volume
1,276,945
3.00 Day's Range 3.34
1.2514 52 Week Range 6.23
Market Cap
240.428M
Previous Close
3.085
Open
3.10
Last Trade
3
@
3.295
Last Trade Time
13:40:19
Financial Volume
$ 4,117,949
VWAP
3.2248
Average Volume (3m)
3,049,547
Shares Outstanding
73,301,201
Dividend Yield
-
PE Ratio
-30.54
Earnings Per Share (EPS)
-0.11
Revenue
50.58M
Net Profit
-7.87M

About Aquestive Therapeutics Inc

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aquestive.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AQST. The last closing price for Aquestive Therapeutics was $3.09. Over the last year, Aquestive Therapeutics shares have traded in a share price range of $ 1.2514 to $ 6.23.

Aquestive Therapeutics currently has 73,301,201 shares outstanding. The market capitalization of Aquestive Therapeutics is $240.43 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -30.54.

AQST Latest News

More News

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives...

6 hours ago
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 07 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 07 2024
Edgar (US Regulatory)

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Met all endpoints in Phase 3 pivotal study for Anaphylm™ (epinephrine) Sublingual Film in first quarter 2024 when compared to EpiPen® and other injectors used for the treatment of anaphylaxisOn...

May 07 2024
GlobeNewswire Inc.

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film

Libervant is the first and only FDA approved orally administered rescue product for the treatment of seizure clusters in patients ages 2 to 5Announces immediate availability of Libervant 5mg...

April 29 2024
GlobeNewswire Inc.

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

WARREN, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

April 25 2024
GlobeNewswire Inc.

Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful...

April 12 2024
GlobeNewswire Inc.

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

WARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

April 01 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.11-3.235294117653.43.62.9117509023.31024959CS
4-1.05-24.19354838714.344.542.9126552293.84163457CS
120.5821.40221402212.716.232.4530495474.21311547CS
261.6499.39393939391.656.231.5517477983.86887717CS
521.0949.54545454552.26.231.251410655583.49502055CS
156-0.15-4.360465116283.446.40.6187169242.99263197CS
260-1.23-27.21238938054.52100.6187157424.01725474CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CPOPPop Culture Group Company Ltd
$ 2.955
(73.82%)
71.74M
SEZLSezzle Inc
$ 76.26
(70.45%)
601.95k
CCSIConcensus Cloud Solutions Inc
$ 18.44
(39.38%)
684.55k
EMBCEmbecta Corporation
$ 13.48
(31.26%)
1.83M
MCRBSeres Therapeutics Inc
$ 0.9768
(30.34%)
13.76M
EMKREMCORE Corporation
$ 1.10
(-62.07%)
4.5M
TIVCTivic Health Systems Inc
$ 0.5625
(-58.02%)
7.74M
CTMXCytomX Therapeutics Inc
$ 2.3627
(-43.61%)
27.19M
RAPTRAPT Therapeutics Inc
$ 4.6401
(-41.85%)
3.34M
CDLXCardlytics Inc
$ 9.30
(-36.30%)
7.24M
GWAVGreenwave Technology Solutions Inc
$ 0.0691
(18.93%)
151.91M
SGDSafe and Green Development Corporation
$ 0.8075
(30.24%)
92.4M
CPOPPop Culture Group Company Ltd
$ 2.955
(73.82%)
71.74M
SQQQProShares UltraPro Short QQQ
$ 10.6869
(-0.49%)
69.41M
FFIEFaraday Future Intelligent Electric Inc
$ 0.0399
(-4.55%)
64.15M

AQST Discussion

View Posts
PonkenPlonken PonkenPlonken 2 weeks ago
added. Great science and beautiful chart.
Offerings became bullish.. dont you know?
👍️0
52172 52172 2 weeks ago
Is a bargain
👍️0
Monksdream Monksdream 3 weeks ago
AQST under $5

👍️0
52172 52172 3 weeks ago
Big turn around imminent
👍️0
52172 52172 1 month ago
Yessir absolutely
👍️0
Monksdream Monksdream 1 month ago
In other words you’re confident about this one from the clinical stage drug discovery sector
👍️0
52172 52172 1 month ago
Not for long
👍️0
Monksdream Monksdream 1 month ago
AQST under $5
👍️0
glenn1919 glenn1919 2 months ago
AQST................................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
AQST new 52 week hi
👍️0
glenn1919 glenn1919 2 months ago
AQST...........................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
I HATE YOU NOW..LOL
👍️0
Monksdream Monksdream 2 months ago
AQST new 52 week high
👍️0
glenn1919 glenn1919 2 months ago
AQST.....................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
👍️0
52172 52172 2 months ago
Headed much higher!
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST..EXIT...MASSIVE PLAY
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST...BREAKING 4 BUCKS...BEAST
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST...MONSTER
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST monster bio by the master trend
👍️0
glenn1919 glenn1919 2 months ago
AQST.......................................https://stockcharts.com/h-sc/ui?s=AQST&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 2 months ago
AQST new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AQST...NEXT BIO WEEKLY BEAST
👍️0
52172 52172 2 months ago
Just the beginning
👍️0
Monksdream Monksdream 3 months ago
AQST new 52 week high
👍️0
Sierra20 Sierra20 4 months ago
Offering coming probably soon.
👍️0
Monksdream Monksdream 4 months ago
AQST new 52 week high
👍️0
shankapotamus shankapotamus 1 year ago
Initiating this one. Fantastic turnaround by company leadership. Look at the ER from last night and see for yourself.
👍️0
trendzone trendzone 2 years ago
Toxic slobs is more like it.
👍️0
crudeoil24 crudeoil24 2 years ago
On going S-3 shelf placement!

AQST
👍️0
crudeoil24 crudeoil24 2 years ago
Aquestive Therapeutics Announces EPIPHAST II Trial Data For AQST-109; Says 'AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen Tmax of 22.5 minutes'
7:05 am ET September 27, 2022 (Benzinga) Print
AQST-109 median time to maximum concentration (Tmax) of 12 minutes was faster than EpiPen® Tmax of 22.5 minutes
AQST-109 repeat dosing provided significantly higher drug plasma concentrations with a Tmax of 8 minutes after administration
Changes in systolic blood pressure and heart rate were similar after a single dose of AQST-109 when compared to a single dose of EpiPen
End-of-Phase 2 meeting with FDA scheduled for fourth quarter 2022 and remaining clinical studies will commence thereafter
Company hosts conference call at 8:00 am ET on September 27, 2022
👍️0
The Night Stalker The Night Stalker 2 years ago
https://www.stockscores.com/chart.asp?TickerSymbol=aqst%20&TimeRange=1825&Interval=m&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
👍️0
The Night Stalker The Night Stalker 2 years ago
me=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=200&Indicator1=AccDist&Indicator2=CMF&Indicator3=StochRSI&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen
👍️0
The Night Stalker The Night Stalker 2 years ago
nice
👍️0
The Night Stalker The Night Stalker 2 years ago
like this
👍️0
The Night Stalker The Night Stalker 2 years ago
strange POS
👍️0
The Night Stalker The Night Stalker 2 years ago
strange POS
👍️0
TheFinalCD TheFinalCD 2 years ago
https://ih.advfn.com/stock-market/NASDAQ/aquestive-therapeutics-AQST/stock-news/88375724/aquestive-therapeutics-reports-positive-initial-to
👍️0
Chrisny73 Chrisny73 2 years ago
Quite the hair cut since the delay. I bought in at 4.38 and will buy more if it drops further
👍️0
Jake L Jake L 2 years ago
AQST - FDA Approval Insight

👍️0
Jake L Jake L 2 years ago
AQST - Tuesday Rundown, Wednesday Expectations

👍️0
Aarin Aarin 3 years ago
Parabolic chart for $AQST. PDUFA is on deck.

👍️0
Jake L Jake L 3 years ago
AQST - Update

👍️0
Jake L Jake L 3 years ago
AQST - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
AQST - Update

👍️0
Jake L Jake L 3 years ago
AQST - Thursday Rundown, Friday Expectations

👍️0
Jake L Jake L 3 years ago
AQST - Update Morning Report

👍️0
Jake L Jake L 3 years ago
AQST - Tuesday Rundown, Wednesday Expectations

👍️0
Jake L Jake L 3 years ago
AQST - Morning Report

👍️0
Jake L Jake L 3 years ago
AQST - Monday Morning Report

👍️0

Your Recent History

NASDAQ
AQST
Aquestive Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved